Download the free e-book on peptides, hormones and pharmaceuticals for longevity, health and performance here: get the e-book
There is an organ that sits at the base of the throat, weighs less than an ounce, and sets the metabolic tempo for virtually every biological process in the body. Its hormones determine how fast cells burn energy, how quickly the heart beats, how efficiently the gut moves, how sharply the brain processes information, how well the body maintains its temperature, and how effectively every other hormone in the system does its job.
That organ is the thyroid gland. And despite its central role in the biological infrastructure that every optimization protocol is built on, thyroid function receives surprisingly little attention in the peptide and optimization conversation — treated more as a separate medical category than as the foundational metabolic variable it actually is.
Understanding what the thyroid does, how its function declines and gets missed, how it interacts with everything else in an optimization protocol, and what to do about suboptimal thyroid function is genuinely foundational knowledge for anyone serious about optimization.
What the thyroid actually does
The thyroid gland produces two primary hormones: thyroxine, known as T4, and triiodothyronine, known as T3. T4 is the more abundant and longer-acting of the two, functioning primarily as a precursor that is converted to the more biologically active T3 in peripheral tissues throughout the body. T3 is the hormone that actually enters cells and binds to thyroid hormone receptors in the cell nucleus, directly influencing gene expression and cellular metabolism.
Thyroid hormones regulate the basal metabolic rate — the rate at which cells consume oxygen and produce energy at rest. Every cell in the body has thyroid hormone receptors. Every cell's metabolic rate is influenced by thyroid hormone availability. This is why thyroid dysfunction produces symptoms that span virtually every organ system: the brain, the heart, the digestive system, the musculoskeletal system, the skin, the reproductive system, and the immune system all function at rates set in part by thyroid hormone levels.
When thyroid hormone is adequate, cells produce energy efficiently, metabolism runs at the right tempo, and every other biological system functions within its designed parameters. When thyroid hormone is insufficient, cellular energy production slows, the metabolic rate falls, and every system that depends on adequate cellular energy begins to function below its capacity.
The conversion problem
Most thyroid hormone produced by the gland is T4. Most thyroid hormone action in the body requires T3. The conversion of T4 to T3 happens primarily in the liver, kidneys, and peripheral tissues through the action of enzymes called deiodinases, and this conversion step is where a significant amount of subclinical thyroid dysfunction occurs without appearing on the standard thyroid screening test.
The standard thyroid screen measures TSH — thyroid stimulating hormone produced by the pituitary — and often T4 only. This approach identifies overt primary hypothyroidism, where the thyroid gland itself is failing to produce adequate T4. It does not identify conversion problems, where the gland produces adequate T4 but peripheral conversion to T3 is impaired, leaving the person with normal TSH and T4 but inadequate T3 at the cellular level.
Several factors impair T4 to T3 conversion that are directly relevant to the optimization population: chronic stress and elevated cortisol, caloric restriction and low carbohydrate intake, inflammation, selenium deficiency, certain medications, and the physiological stress of significant illness or surgery. People in caloric restriction while pursuing fat loss, people under chronic psychological stress, and people with significant systemic inflammation — which includes a substantial proportion of anyone pursuing optimization — are at elevated risk for impaired conversion that standard screening will miss.
The difference between measuring TSH and T4 alone versus measuring TSH, free T4, free T3, and reverse T3 together is the difference between screening for overt thyroid failure and actually understanding thyroid hormone status at the cellular level. Comprehensive thyroid panels that include free T3 and reverse T3 are standard in functional and optimization medicine precisely because the additional markers reveal dysfunction that the abbreviated panel misses.
Reverse T3 and the hibernation signal
Reverse T3 deserves specific mention because it represents one of the most clinically significant and most commonly overlooked aspects of thyroid function in the optimization context.
Reverse T3 is an inactive isomer of T3 produced when T4 is converted by a different enzyme pathway than the one that produces active T3. Rather than activating thyroid receptors, reverse T3 blocks them — it occupies thyroid receptor binding sites without activating them, effectively reducing the cellular response to whatever active T3 is present.
The body increases reverse T3 production in response to physiological stress signals including caloric restriction, chronic illness, significant psychological stress, and high cortisol. The evolutionary logic is that these signals indicate conditions where reducing metabolic rate is adaptive — conserving energy when resources are scarce or when the body is under significant stress is a survival strategy. The result in the modern context is that people under chronic stress or in caloric restriction often have elevated reverse T3 that is slowing their metabolism independent of what their TSH and T4 values show.
For anyone who has experienced unexplained metabolic slowdown during a caloric deficit, or who has found their fat loss stalling despite maintaining their protocol, elevated reverse T3 is one of the most commonly overlooked explanations. It does not appear on standard thyroid panels and is not typically measured in conventional medicine.
How thyroid function interacts with everything else in a protocol
The thyroid does not operate in isolation. Its function is deeply intertwined with every other hormonal and metabolic system in the body, and optimizing those systems without addressing thyroid function produces results that are systematically limited by the metabolic ceiling the thyroid sets.
Growth hormone and thyroid function have a bidirectional relationship. Adequate thyroid hormone is required for normal growth hormone production and action. Hypothyroidism reduces growth hormone secretion and impairs the tissue response to growth hormone. Conversely, growth hormone supports T4 to T3 conversion. Running growth hormone peptides in the context of subclinical hypothyroidism produces blunted results because the hormonal environment those peptides are trying to optimize is already constrained by inadequate thyroid hormone at the cellular level.
Testosterone and thyroid hormones interact through multiple mechanisms. Hypothyroidism elevates sex hormone binding globulin, which reduces free testosterone availability even when total testosterone is adequate. It impairs the conversion of testosterone to its active metabolites. And it reduces the sensitivity of testosterone receptors, making the testosterone that is available less effective at its target tissues. Men pursuing testosterone optimization with unaddressed subclinical hypothyroidism are working against a system that is limiting the effectiveness of that optimization at multiple levels simultaneously.
Estrogen metabolism depends on adequate thyroid function for proper hepatic processing. Women with hypothyroidism frequently experience estrogen dominance patterns not because they are producing too much estrogen but because the liver is not clearing it efficiently, producing relative excess despite normal production levels.
Mitochondrial energy production is directly regulated by thyroid hormone. T3 upregulates the expression of mitochondrial proteins involved in the electron transport chain, supporting the ATP production capacity that every cellular function depends on. NAD+ and the mitochondrial compounds covered in the longevity section of this publication address mitochondrial function through their own mechanisms, but they are doing so within a framework that thyroid hormone availability fundamentally shapes.
Insulin sensitivity is affected by thyroid function through the effects of thyroid hormone on glucose transporter expression and cellular glucose metabolism. Hypothyroidism contributes to insulin resistance independently of other factors, which means addressing thyroid function is part of addressing the upstream metabolic dysfunction that insulin resistance represents.
Symptoms that suggest thyroid evaluation is warranted
The symptoms of subclinical hypothyroidism are often attributed to other causes because they are nonspecific and overlap with symptoms of many other conditions. They include persistent fatigue that is not explained by sleep quality or quantity, difficulty losing weight despite caloric deficit and appropriate activity, cold sensitivity particularly in the hands and feet, dry skin and hair, hair loss including loss of the outer third of the eyebrows, cognitive sluggishness and difficulty with word recall, constipation, low mood and depression, elevated cholesterol despite dietary management, and reduced heart rate and blood pressure in the absence of cardiovascular fitness.
None of these individually points unambiguously to thyroid dysfunction. All of them together, particularly in someone who has addressed sleep, stress, nutrition, and activity and still experiences a cluster of these symptoms, warrant a comprehensive thyroid panel rather than TSH alone.
What can be done
For overt hypothyroidism, thyroid hormone replacement with levothyroxine (T4) or the combination of levothyroxine and liothyronine (T3) is the standard and well-established medical approach. Compounded thyroid preparations that combine T4 and T3 in ratios calibrated to individual response are available through the platform for people who do not achieve adequate symptom resolution on T4 alone — a significant subset of hypothyroid patients whose conversion from T4 to T3 remains inadequate even with T4 replacement.
For subclinical cases where the issue is impaired conversion or elevated reverse T3 rather than inadequate T4 production, the approach includes addressing the upstream drivers — reducing cortisol burden through stress management, ensuring adequate selenium and zinc for deiodinase function, managing systemic inflammation, and avoiding overly aggressive caloric restriction that the body interprets as starvation stress.
The optimization protocol context provides several additional levers. GLP-1 receptor agonists reduce the inflammatory and metabolic stress burden that impairs conversion. Growth hormone peptides that improve sleep quality reduce the cortisol dysregulation that suppresses conversion during overnight recovery. Addressing gut health reduces the systemic inflammation that interferes with T4 to T3 conversion in peripheral tissues.
Why this matters before adding more compounds
The most practical implication of the thyroid's role as the metabolic regulator that every other optimization effort depends on is simple. Before layering in multiple peptide compounds, growth hormone peptides, and longevity compounds, understanding thyroid function through a comprehensive panel is one of the highest-yield diagnostic steps available.
A person running an extensive optimization protocol on a background of subclinical hypothyroidism is running that protocol at a metabolic disadvantage that no compound in the catalogue directly addresses. The thyroid sets the rate at which everything else works. Getting that rate right before building the rest of the protocol on top of it is not a separate medical consideration. It is the foundation the protocol stands on.
This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making any changes to your health regimen. For more information visit www.peakformrx.health